Poland leans towards shorter data exclusivity period, one year market protection [Advocacy Lab Content]

Warsaw has sided with the European Commission on the length of the Regulatory Data Protection (RDP) period in the EU Pharma Package. Poland advocates that the incentives scheme should focus on market protection and not last more than a year.